Bile acid–gut microbiota axis in inflammatory bowel disease: from bench to bedside

M Yang, Y Gu, L Li, T Liu, X Song, Y Sun, X Cao… - Nutrients, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder of the
gastrointestinal tract, with increasing prevalence, and its pathogenesis remains unclear …

The microbiota and the gut–liver axis in primary sclerosing cholangitis

JR Hov, TH Karlsen - Nature Reviews Gastroenterology & Hepatology, 2023 - nature.com
Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …

Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics

X Yuan, B Chen, Z Duan, Z Xia, Y Ding, T Chen… - Gut …, 2021 - Taylor & Francis
Patients with ulcerative colitis (UC) have a high prevalence of mental disorders, such as
depression and anxiety. Gut microbiota imbalance and disturbed metabolism have been …

Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis

F Hinrichsen, J Hamm, M Westermann, L Schröder… - Cell Metabolism, 2021 - cell.com
Hexokinases (HK) catalyze the first step of glycolysis limiting its pace. HK2 is highly
expressed in gut epithelium, contributes to immune responses, and is upregulated during …

Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis

YS Kim, EH Hurley, Y Park, S Ko - Experimental & Molecular Medicine, 2023 - nature.com
The close relationship between primary sclerosing cholangitis (PSC) and inflammatory
bowel disease (IBD) provides a good opportunity to comprehend the gut–liver axis. The gut …

Cholestasis: Exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies

L Yu, Y Liu, S Wang, Q Zhang, J Zhao, H Zhang… - Gut …, 2023 - Taylor & Francis
Cholestasis is a condition characterized by the abnormal production or excretion of bile, and
it can be induced by a variety of causes, the factors of which are extremely complex …

A random forest based biomarker discovery and power analysis framework for diagnostics research

A Acharjee, J Larkman, Y Xu, VR Cardoso… - BMC medical …, 2020 - Springer
Background Biomarker identification is one of the major and important goal of functional
genomics and translational medicine studies. Large scale–omics data are increasingly …

[HTML][HTML] Gut microbiome in primary sclerosing cholangitis: A review

R Little, E Wine, BM Kamath, AM Griffiths… - World journal of …, 2020 - ncbi.nlm.nih.gov
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by
biliary inflammation and stricturing. Exploration of the pathogenesis of PSC in light of its …

The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts

T Liwinski, M Heinemann, C Schramm - Seminars in Immunopathology, 2022 - Springer
Autoimmune liver diseases are a group of immune-mediated liver diseases with three
distinct entities, including autoimmune hepatitis, primary biliary cholangitis, and primary …

Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcare

SK Gill, A Karwath, HW Uh, VR Cardoso… - European Heart …, 2023 - academic.oup.com
Artificial intelligence (AI) is increasingly being utilized in healthcare. This article provides
clinicians and researchers with a step-wise foundation for high-value AI that can be applied …